TECHNOLOGY UPDATE 2014

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

EuroIntervention 2014;10:U120-U128. DOI: 10.4244/EIJV10SUA18

Vinayak Bapat1*, FRCS (CTh); Lutz Buellesfeld2, MD; Mark D. Peterson3, MD; Jane Hancock1, FRCP; David Reineke2, MD; Chris Buller3, MD; Thierry Carrel2, MD; Fabien Praz2, MD; Ronal Rajani1, FRCP; Neil Fam3, MD; Han Kim3, MD; Simon Redwood1, FRCP; Christopher Young1, FRCS (CTh); Christopher Munns1, FRCA; Stephan Windecker2, MD; Martyn Thomas1, FRCP

1. Department of Cardiothoracic Surgery and Cardiology, St. Thomas’ Hospital, London, United Kingdom; 2. Department of Cardiac Surgery and Cardiology, Bern University Hospital, Bern, Switzerland; 3. Department of Cardiac Surgery and Cardiology, St. Michae

Transcatheter aortic valve implantation (TAVI) has demonstrated the feasibility of treating valvular heart disease with transcatheter therapy. On the back of this success, various transcatheter concepts are being evaluated to

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

mitralregurgitationtranscatheter aortic valve implantationvalve replacement

Share on Facebook Share on Twitter Share on Linkedin

Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device

Latest news